Nutex Health, Inc.
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Nutex Health, Inc. Nutex Health, Inc. (NASDAQ: NUTX) operates as a physician-led healthcare management and operations company focused on integrated care delivery; it manages a Hospital Division that owns, develops and operates micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs) providing 24/7 emergency services, inpatient care, behavioral health, onsite imaging including CT scans, X-rays, MRIs and ultrasounds, certified laboratories and inpatient pharmacies across over 24 facilities in 11 states; a Population Health Management Division that owns and operates Independent Physician Associations (IPAs) and Management Services Organizations (MSOs) offering administrative support, cloud-based data aggregation via its Clinigence platform for value-based care and risk-bearing physician networks; and a Real Estate Division that owns and leases land and hospital buildings to affiliated entities. Headquartered in Houston, Texas and founded in 2011, the company targets primary care-centric populations in the United States with turnkey solutions encompassing real estate acquisition, facility design, staffing, billing, credentialing and medical coding. Recent developments include the August 2023 acquisition of Population Health Associates and Managed Care Insurance Consultants adding approximately 112 primary care physicians and 4400 managed care patients in Florida to enhance synergies with its South Florida Physicians IPA and leverage proprietary population health technology for optimized medical cost ratios; plans to open 5-6 additional micro-hospitals in Florida markets including Tampa, Miami, Orlando and Jacksonville by end-2025; restated first quarter 2025 financial results reflecting total revenue of $211.8 million, up 214% year-over-year; and expansion to 24 facilities across 11 states as of late 2025.
Kuehn Law Encourages Investors of Nutex Health, Inc. to Contact Law Firm
Nutex Health Inc. (NUTX) Q1 2026 Earnings Call Transcript
NUTEX HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Kuehn Law Encourages Investors of Nutex Health, Inc. to Contact Law Firm
Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call
Reviewing GoodRx (NASDAQ:GDRX) & Nutex Health (NASDAQ:NUTX)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX
Kuehn Law Encourages Investors of Nutex Health, Inc. to Contact Law Firm
Lowey Dannenberg, P.C. is Investigating Nutex Health, Inc. (Nasdaq: NUTX) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX
Omada Health (NASDAQ:OMDA) vs. Nutex Health (NASDAQ:NUTX) Financial Contrast
Lowey Dannenberg, P.C. is Investigating Nutex Health, Inc. (Nasdaq: NUTX) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
Nutex Health Inc. (NUTX) Q4 2025 Earnings Call Transcript
INVESTOR ALERT: Investigation of Nutex Health, Inc. (NUTX) announced by Holzer & Holzer, LLC
Nutex Health Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through the Firm's Investigation
NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM
Kuehn Law Encourages Investors of Nutex Health, Inc. to Contact Law Firm
Nutex Health: The $387 Million Receivables Problem And The Legislative Silver Bullet
Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call